Researcher Highlight
-
Researcher Highlight: Marsalas Whitaker
Marsalas Whitaker, 2nd year Biomedical Engineering graduate student in the Giorgio Lab The level of epidermal growth factor receptor (EGFR) activation is reflected in subpopulations of extracellular vesicles (EVs) originating from cancerous tissue that contain EGFR. Such EVs can be assessed using methods like immunoblots and flow cytometry. One pitfall… Read MoreJan. 5, 2023
-
Researcher Highlights: Alberto Esteban Linares and Simon Ward
Alberto Esteban Linares, PhD candidate of Mechanical Engineering in the Li lab Microfluidic platforms can play a transformative role in ex vivo tissue culture and physiological and pathological studies as they allow for precise control of cell microenvironment alike in vitro models, while the cellular matrix architecture similar to… Read MoreAug. 26, 2022
-
Researcher Highlights: Ethan Lippmann and Janet Macdonald
Ethan Lippmann, Associate Professor of Chemical and Biomolecular Engineering The majority of neurodegenerative diseases such as Alzheimer’s are incurable, and the incidence of neurodegenerative disease is expected to increase concurrently with worldwide life expectancies. The Lippmann lab combines principles from engineering, neuroscience, and regenerative medicine to model, understand, and ultimately… Read MoreAug. 26, 2022
-
Spring 2022 Faculty Research Highlights
Spring Newsletter 2022 Faculty Research Highlights: Cynthia Reinhart-King, Cornelius Vanderbilt Professor of Engineering, President-Elect of the Biomedical Engineering Society Cancer is the second leading cause of death in the US, and mortality is largely caused by the spread of a primary tumor to secondary sites. The Reinhart-King… Read MoreDec. 13, 2021
-
Spring 2022 Graduate Student Research Highlights
Spring Newsletter 2022 graduate student research highlights: Ella Hoogenboezem, 5th year graduate student in the Duvall lab Short interfering RNA (siRNA) is a powerful gene silencing platform that has the potential to silence tumor-driving genes. However, siRNA medicines for tumor delivery have remained clinically elusive. In… Read MoreDec. 13, 2021